Global Intramuscular Injector Market Research Report 2023

Publisher Name :
Date: 01-Dec-2023
No. of pages: 107
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intramuscular Injector market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Antares Pharma

- Endo International Plc

- Bioject Medical Technologies

- PharmaJetMedical International Technology

- National Medical Products

- Valeritas

- European Pharma Group

- PenJet Corporation

- Becton

- Dickinson

- Injex Pharma AG

- Crossject SA

- Solace Biotech

- Sanify Healthcare Private Limited

- Novosanis

- Vata

- Kaleo

Segment by Type

- Pre-fillable Injection System

- Fillable Needle-free Injectors

Segment by Application

- Hospitals

- Clinics

- Ambulatory Surgery Centers

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

The Intramuscular Injector report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global Intramuscular Injector Market Research Report 2023

Table of Contents
1 Intramuscular Injector Market Overview
1.1 Product Overview and Scope of Intramuscular Injector
1.2 Intramuscular Injector Segment by Type
1.2.1 Global Intramuscular Injector Market Value Comparison by Type (2023-2029)
1.2.2 Pre-fillable Injection System
1.2.3 Fillable Needle-free Injectors
1.3 Intramuscular Injector Segment by Application
1.3.1 Global Intramuscular Injector Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Global Intramuscular Injector Market Size Estimates and Forecasts
1.4.1 Global Intramuscular Injector Revenue 2018-2029
1.4.2 Global Intramuscular Injector Sales 2018-2029
1.4.3 Global Intramuscular Injector Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intramuscular Injector Market Competition by Manufacturers
2.1 Global Intramuscular Injector Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intramuscular Injector Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intramuscular Injector Average Price by Manufacturers (2018-2023)
2.4 Global Intramuscular Injector Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intramuscular Injector, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular Injector, Product Type & Application
2.7 Intramuscular Injector Market Competitive Situation and Trends
2.7.1 Intramuscular Injector Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intramuscular Injector Players Market Share by Revenue
2.7.3 Global Intramuscular Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intramuscular Injector Retrospective Market Scenario by Region
3.1 Global Intramuscular Injector Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intramuscular Injector Global Intramuscular Injector Sales by Region: 2018-2029
3.2.1 Global Intramuscular Injector Sales by Region: 2018-2023
3.2.2 Global Intramuscular Injector Sales by Region: 2024-2029
3.3 Global Intramuscular Injector Global Intramuscular Injector Revenue by Region: 2018-2029
3.3.1 Global Intramuscular Injector Revenue by Region: 2018-2023
3.3.2 Global Intramuscular Injector Revenue by Region: 2024-2029
3.4 North America Intramuscular Injector Market Facts & Figures by Country
3.4.1 North America Intramuscular Injector Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intramuscular Injector Sales by Country (2018-2029)
3.4.3 North America Intramuscular Injector Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intramuscular Injector Market Facts & Figures by Country
3.5.1 Europe Intramuscular Injector Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intramuscular Injector Sales by Country (2018-2029)
3.5.3 Europe Intramuscular Injector Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular Injector Market Facts & Figures by Country
3.6.1 Asia Pacific Intramuscular Injector Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intramuscular Injector Sales by Country (2018-2029)
3.6.3 Asia Pacific Intramuscular Injector Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intramuscular Injector Market Facts & Figures by Country
3.7.1 Latin America Intramuscular Injector Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intramuscular Injector Sales by Country (2018-2029)
3.7.3 Latin America Intramuscular Injector Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intramuscular Injector Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular Injector Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intramuscular Injector Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intramuscular Injector Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intramuscular Injector Sales by Type (2018-2029)
4.1.1 Global Intramuscular Injector Sales by Type (2018-2023)
4.1.2 Global Intramuscular Injector Sales by Type (2024-2029)
4.1.3 Global Intramuscular Injector Sales Market Share by Type (2018-2029)
4.2 Global Intramuscular Injector Revenue by Type (2018-2029)
4.2.1 Global Intramuscular Injector Revenue by Type (2018-2023)
4.2.2 Global Intramuscular Injector Revenue by Type (2024-2029)
4.2.3 Global Intramuscular Injector Revenue Market Share by Type (2018-2029)
4.3 Global Intramuscular Injector Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intramuscular Injector Sales by Application (2018-2029)
5.1.1 Global Intramuscular Injector Sales by Application (2018-2023)
5.1.2 Global Intramuscular Injector Sales by Application (2024-2029)
5.1.3 Global Intramuscular Injector Sales Market Share by Application (2018-2029)
5.2 Global Intramuscular Injector Revenue by Application (2018-2029)
5.2.1 Global Intramuscular Injector Revenue by Application (2018-2023)
5.2.2 Global Intramuscular Injector Revenue by Application (2024-2029)
5.2.3 Global Intramuscular Injector Revenue Market Share by Application (2018-2029)
5.3 Global Intramuscular Injector Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Corporation Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Antares Pharma Intramuscular Injector Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Endo International Plc
6.2.1 Endo International Plc Corporation Information
6.2.2 Endo International Plc Description and Business Overview
6.2.3 Endo International Plc Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Endo International Plc Intramuscular Injector Product Portfolio
6.2.5 Endo International Plc Recent Developments/Updates
6.3 Bioject Medical Technologies
6.3.1 Bioject Medical Technologies Corporation Information
6.3.2 Bioject Medical Technologies Description and Business Overview
6.3.3 Bioject Medical Technologies Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bioject Medical Technologies Intramuscular Injector Product Portfolio
6.3.5 Bioject Medical Technologies Recent Developments/Updates
6.4 PharmaJetMedical International Technology
6.4.1 PharmaJetMedical International Technology Corporation Information
6.4.2 PharmaJetMedical International Technology Description and Business Overview
6.4.3 PharmaJetMedical International Technology Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PharmaJetMedical International Technology Intramuscular Injector Product Portfolio
6.4.5 PharmaJetMedical International Technology Recent Developments/Updates
6.5 National Medical Products
6.5.1 National Medical Products Corporation Information
6.5.2 National Medical Products Description and Business Overview
6.5.3 National Medical Products Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.5.4 National Medical Products Intramuscular Injector Product Portfolio
6.5.5 National Medical Products Recent Developments/Updates
6.6 Valeritas
6.6.1 Valeritas Corporation Information
6.6.2 Valeritas Description and Business Overview
6.6.3 Valeritas Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Valeritas Intramuscular Injector Product Portfolio
6.6.5 Valeritas Recent Developments/Updates
6.7 European Pharma Group
6.6.1 European Pharma Group Corporation Information
6.6.2 European Pharma Group Description and Business Overview
6.6.3 European Pharma Group Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.4.4 European Pharma Group Intramuscular Injector Product Portfolio
6.7.5 European Pharma Group Recent Developments/Updates
6.8 PenJet Corporation
6.8.1 PenJet Corporation Corporation Information
6.8.2 PenJet Corporation Description and Business Overview
6.8.3 PenJet Corporation Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.8.4 PenJet Corporation Intramuscular Injector Product Portfolio
6.8.5 PenJet Corporation Recent Developments/Updates
6.9 Becton
6.9.1 Becton Corporation Information
6.9.2 Becton Description and Business Overview
6.9.3 Becton Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Becton Intramuscular Injector Product Portfolio
6.9.5 Becton Recent Developments/Updates
6.10 Dickinson
6.10.1 Dickinson Corporation Information
6.10.2 Dickinson Description and Business Overview
6.10.3 Dickinson Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dickinson Intramuscular Injector Product Portfolio
6.10.5 Dickinson Recent Developments/Updates
6.11 Injex Pharma AG
6.11.1 Injex Pharma AG Corporation Information
6.11.2 Injex Pharma AG Intramuscular Injector Description and Business Overview
6.11.3 Injex Pharma AG Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Injex Pharma AG Intramuscular Injector Product Portfolio
6.11.5 Injex Pharma AG Recent Developments/Updates
6.12 Crossject SA
6.12.1 Crossject SA Corporation Information
6.12.2 Crossject SA Intramuscular Injector Description and Business Overview
6.12.3 Crossject SA Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Crossject SA Intramuscular Injector Product Portfolio
6.12.5 Crossject SA Recent Developments/Updates
6.13 Solace Biotech
6.13.1 Solace Biotech Corporation Information
6.13.2 Solace Biotech Intramuscular Injector Description and Business Overview
6.13.3 Solace Biotech Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Solace Biotech Intramuscular Injector Product Portfolio
6.13.5 Solace Biotech Recent Developments/Updates
6.14 Sanify Healthcare Private Limited
6.14.1 Sanify Healthcare Private Limited Corporation Information
6.14.2 Sanify Healthcare Private Limited Intramuscular Injector Description and Business Overview
6.14.3 Sanify Healthcare Private Limited Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sanify Healthcare Private Limited Intramuscular Injector Product Portfolio
6.14.5 Sanify Healthcare Private Limited Recent Developments/Updates
6.15 Novosanis
6.15.1 Novosanis Corporation Information
6.15.2 Novosanis Intramuscular Injector Description and Business Overview
6.15.3 Novosanis Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novosanis Intramuscular Injector Product Portfolio
6.15.5 Novosanis Recent Developments/Updates
6.16 Vata
6.16.1 Vata Corporation Information
6.16.2 Vata Intramuscular Injector Description and Business Overview
6.16.3 Vata Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Vata Intramuscular Injector Product Portfolio
6.16.5 Vata Recent Developments/Updates
6.17 Kaleo
6.17.1 Kaleo Corporation Information
6.17.2 Kaleo Intramuscular Injector Description and Business Overview
6.17.3 Kaleo Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Kaleo Intramuscular Injector Product Portfolio
6.17.5 Kaleo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular Injector Industry Chain Analysis
7.2 Intramuscular Injector Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular Injector Production Mode & Process
7.4 Intramuscular Injector Sales and Marketing
7.4.1 Intramuscular Injector Sales Channels
7.4.2 Intramuscular Injector Distributors
7.5 Intramuscular Injector Customers
8 Intramuscular Injector Market Dynamics
8.1 Intramuscular Injector Industry Trends
8.2 Intramuscular Injector Market Drivers
8.3 Intramuscular Injector Market Challenges
8.4 Intramuscular Injector Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Intramuscular Injector Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Intramuscular Injector Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Intramuscular Injector Market Competitive Situation by Manufacturers in 2022
Table 4. Global Intramuscular Injector Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intramuscular Injector Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intramuscular Injector Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intramuscular Injector Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intramuscular Injector Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intramuscular Injector, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Intramuscular Injector, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intramuscular Injector, Product Type & Application
Table 12. Global Key Manufacturers of Intramuscular Injector, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intramuscular Injector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Injector as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intramuscular Injector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Intramuscular Injector Sales by Region (2018-2023) & (K Units)
Table 18. Global Intramuscular Injector Sales Market Share by Region (2018-2023)
Table 19. Global Intramuscular Injector Sales by Region (2024-2029) & (K Units)
Table 20. Global Intramuscular Injector Sales Market Share by Region (2024-2029)
Table 21. Global Intramuscular Injector Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intramuscular Injector Revenue Market Share by Region (2018-2023)
Table 23. Global Intramuscular Injector Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Intramuscular Injector Revenue Market Share by Region (2024-2029)
Table 25. North America Intramuscular Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Intramuscular Injector Sales by Country (2018-2023) & (K Units)
Table 27. North America Intramuscular Injector Sales by Country (2024-2029) & (K Units)
Table 28. North America Intramuscular Injector Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intramuscular Injector Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Intramuscular Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Intramuscular Injector Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intramuscular Injector Sales by Country (2024-2029) & (K Units)
Table 33. Europe Intramuscular Injector Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intramuscular Injector Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Intramuscular Injector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Intramuscular Injector Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intramuscular Injector Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Intramuscular Injector Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intramuscular Injector Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intramuscular Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Intramuscular Injector Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intramuscular Injector Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Intramuscular Injector Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intramuscular Injector Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Intramuscular Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Intramuscular Injector Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intramuscular Injector Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Intramuscular Injector Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intramuscular Injector Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Intramuscular Injector Sales (K Units) by Type (2018-2023)
Table 51. Global Intramuscular Injector Sales (K Units) by Type (2024-2029)
Table 52. Global Intramuscular Injector Sales Market Share by Type (2018-2023)
Table 53. Global Intramuscular Injector Sales Market Share by Type (2024-2029)
Table 54. Global Intramuscular Injector Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intramuscular Injector Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Intramuscular Injector Revenue Market Share by Type (2018-2023)
Table 57. Global Intramuscular Injector Revenue Market Share by Type (2024-2029)
Table 58. Global Intramuscular Injector Price (USD/Unit) by Type (2018-2023)
Table 59. Global Intramuscular Injector Price (USD/Unit) by Type (2024-2029)
Table 60. Global Intramuscular Injector Sales (K Units) by Application (2018-2023)
Table 61. Global Intramuscular Injector Sales (K Units) by Application (2024-2029)
Table 62. Global Intramuscular Injector Sales Market Share by Application (2018-2023)
Table 63. Global Intramuscular Injector Sales Market Share by Application (2024-2029)
Table 64. Global Intramuscular Injector Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intramuscular Injector Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Intramuscular Injector Revenue Market Share by Application (2018-2023)
Table 67. Global Intramuscular Injector Revenue Market Share by Application (2024-2029)
Table 68. Global Intramuscular Injector Price (USD/Unit) by Application (2018-2023)
Table 69. Global Intramuscular Injector Price (USD/Unit) by Application (2024-2029)
Table 70. Antares Pharma Corporation Information
Table 71. Antares Pharma Description and Business Overview
Table 72. Antares Pharma Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Antares Pharma Intramuscular Injector Product
Table 74. Antares Pharma Recent Developments/Updates
Table 75. Endo International Plc Corporation Information
Table 76. Endo International Plc Description and Business Overview
Table 77. Endo International Plc Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Endo International Plc Intramuscular Injector Product
Table 79. Endo International Plc Recent Developments/Updates
Table 80. Bioject Medical Technologies Corporation Information
Table 81. Bioject Medical Technologies Description and Business Overview
Table 82. Bioject Medical Technologies Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Bioject Medical Technologies Intramuscular Injector Product
Table 84. Bioject Medical Technologies Recent Developments/Updates
Table 85. PharmaJetMedical International Technology Corporation Information
Table 86. PharmaJetMedical International Technology Description and Business Overview
Table 87. PharmaJetMedical International Technology Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. PharmaJetMedical International Technology Intramuscular Injector Product
Table 89. PharmaJetMedical International Technology Recent Developments/Updates
Table 90. National Medical Products Corporation Information
Table 91. National Medical Products Description and Business Overview
Table 92. National Medical Products Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. National Medical Products Intramuscular Injector Product
Table 94. National Medical Products Recent Developments/Updates
Table 95. Valeritas Corporation Information
Table 96. Valeritas Description and Business Overview
Table 97. Valeritas Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Valeritas Intramuscular Injector Product
Table 99. Valeritas Recent Developments/Updates
Table 100. European Pharma Group Corporation Information
Table 101. European Pharma Group Description and Business Overview
Table 102. European Pharma Group Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. European Pharma Group Intramuscular Injector Product
Table 104. European Pharma Group Recent Developments/Updates
Table 105. PenJet Corporation Corporation Information
Table 106. PenJet Corporation Description and Business Overview
Table 107. PenJet Corporation Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. PenJet Corporation Intramuscular Injector Product
Table 109. PenJet Corporation Recent Developments/Updates
Table 110. Becton Corporation Information
Table 111. Becton Description and Business Overview
Table 112. Becton Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Becton Intramuscular Injector Product
Table 114. Becton Recent Developments/Updates
Table 115. Dickinson Corporation Information
Table 116. Dickinson Description and Business Overview
Table 117. Dickinson Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Dickinson Intramuscular Injector Product
Table 119. Dickinson Recent Developments/Updates
Table 120. Injex Pharma AG Corporation Information
Table 121. Injex Pharma AG Description and Business Overview
Table 122. Injex Pharma AG Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Injex Pharma AG Intramuscular Injector Product
Table 124. Injex Pharma AG Recent Developments/Updates
Table 125. Crossject SA Corporation Information
Table 126. Crossject SA Description and Business Overview
Table 127. Crossject SA Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Crossject SA Intramuscular Injector Product
Table 129. Crossject SA Recent Developments/Updates
Table 130. Solace Biotech Corporation Information
Table 131. Solace Biotech Description and Business Overview
Table 132. Solace Biotech Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Solace Biotech Intramuscular Injector Product
Table 134. Solace Biotech Recent Developments/Updates
Table 135. Sanify Healthcare Private Limited Corporation Information
Table 136. Sanify Healthcare Private Limited Description and Business Overview
Table 137. Sanify Healthcare Private Limited Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Sanify Healthcare Private Limited Intramuscular Injector Product
Table 139. Sanify Healthcare Private Limited Recent Developments/Updates
Table 140. Novosanis Corporation Information
Table 141. Novosanis Description and Business Overview
Table 142. Novosanis Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Novosanis Intramuscular Injector Product
Table 144. Novosanis Recent Developments/Updates
Table 145. Vata Corporation Information
Table 146. Vata Description and Business Overview
Table 147. Vata Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Vata Intramuscular Injector Product
Table 149. Vata Recent Developments/Updates
Table 150. Kaleo Corporation Information
Table 151. Kaleo Description and Business Overview
Table 152. Kaleo Intramuscular Injector Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Kaleo Intramuscular Injector Product
Table 154. Kaleo Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Intramuscular Injector Distributors List
Table 158. Intramuscular Injector Customers List
Table 159. Intramuscular Injector Market Trends
Table 160. Intramuscular Injector Market Drivers
Table 161. Intramuscular Injector Market Challenges
Table 162. Intramuscular Injector Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intramuscular Injector
Figure 2. Global Intramuscular Injector Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Intramuscular Injector Market Share by Type in 2022 & 2029
Figure 4. Pre-fillable Injection System Product Picture
Figure 5. Fillable Needle-free Injectors Product Picture
Figure 6. Global Intramuscular Injector Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Intramuscular Injector Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Ambulatory Surgery Centers
Figure 11. Others
Figure 12. Global Intramuscular Injector Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intramuscular Injector Market Size (2018-2029) & (US$ Million)
Figure 14. Global Intramuscular Injector Sales (2018-2029) & (K Units)
Figure 15. Global Intramuscular Injector Average Price (USD/Unit) & (2018-2029)
Figure 16. Intramuscular Injector Report Years Considered
Figure 17. Intramuscular Injector Sales Share by Manufacturers in 2022
Figure 18. Global Intramuscular Injector Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Intramuscular Injector Players: Market Share by Revenue in 2022
Figure 20. Intramuscular Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Intramuscular Injector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Intramuscular Injector Sales Market Share by Country (2018-2029)
Figure 23. North America Intramuscular Injector Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Intramuscular Injector Sales Market Share by Country (2018-2029)
Figure 27. Europe Intramuscular Injector Revenue Market Share by Country (2018-2029)
Figure 28. Germany Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Intramuscular Injector Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Intramuscular Injector Revenue Market Share by Region (2018-2029)
Figure 35. China Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Intramuscular Injector Sales Market Share by Country (2018-2029)
Figure 46. Latin America Intramuscular Injector Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Intramuscular Injector Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Intramuscular Injector Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Intramuscular Injector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Intramuscular Injector by Type (2018-2029)
Figure 56. Global Revenue Market Share of Intramuscular Injector by Type (2018-2029)
Figure 57. Globa
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs